期刊文献+

纳米羟基磷灰石液对人工致龋液pH值的影响 被引量:1

Influence of Nano hydroxyapatite on caries solution pH value
原文传递
导出
摘要 目的观察纳米羟基磷灰石再矿化液对人工致龋液pH值的影响。方法采用60mL∶15g的纳米羟基磷灰石溶液作为再矿化液滴定pH值为4.5的0.1mmol/L人工致龋液,记录每加入0.1mL纳米羟基磷灰石液后人工致龋液pH值的变化,至其无明显改变,并进行统计分析。结果纳米羟基磷灰石与人工致龋液pH值的变化规律符合对数方程:y=5.951+0.185lgx,即:人工致龋液的pH值随纳米羟基磷灰石液的增加而增加,呈正相关,人工致龋液的pH值最终无限接近于7.0。结论纳米羟基磷灰石液能明显改变人工致龋液的pH值,使牙釉质脱矿的酸性环境趋于中性,有利于龋病的预防。 Objective To observe the influence of nano hydroxyapatite remineralization solution on pH value change of artificial cariogenic solution. Methods Artificial cariogenie solution 0.1 mmol/L of pH 4.5 was titrated by 15 g/60 mL nano hydroxyapatite, and was recorded the pH value changes of artificial cariogenic solution when it was added per 0.1 mL nano hydroxyapatite remineralization solution until the pH value had no significant change. The data were statistically analyzed. Results The pH value change of artificial cariogenic solution was in accord with the law of logarithmic equation: y=5.951+0.185lgx, which meant artificial cariogenic solution pH value increased with the increase of nano hydroxyapatite solution and showed a positive correlation. Ultimately, the pH value of artificial cariogenic solution infinitely was closed to 7.0. Conclusion Nano hydroxyapatite solution can change the pH value of artificial cariogenic solution significantly. It makes the enamel demineralization acidic environment neutral, which is conducive to the prevention of dental caries.
出处 《中华实用诊断与治疗杂志》 2013年第4期349-350,354,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 新疆维吾尔自治区自然科学基金(2011211A040) 新疆医科大学创新基金(XJC201145)
关键词 人工致龋液 纳米羟基磷灰石 PH值 Artificial cariogenic solution nano hydroxyapatite pH value
  • 相关文献

参考文献9

  • 1Ronden R A, Houben A J, Teerlink T, et al. Reduced renalplasma clearance does not explain increased plasma asymmetricdimethylarginine in hypertensive subjects with mild to moderaterenal insufficiency [J]. Am J Physiol Renal Physiol,2012,303(1):F149-156.
  • 2Seljeflot I. Plasma asymmetric dimethylarginine in patients withacute decompensation of chronic heart failure[J]. Heart, 2012,98(11):831-832.
  • 3Zairis M N, Patsourakos N G,Tsiaousis G Z,et al. Plasmaasymmetric dimethylarginine and mortality in patients with acutedecompensation of chronic heart failure [J]. Heart, 2012,98(11):860-864.
  • 4Siervo M, Bluck L J. In vivo nitric oxide synthesis, insulinsensitivity,and asymmetric dimethylarginine in obese subjectswithout and with metabolic syndrome[J]. Metabolism,2012? 61(5):680-688.
  • 5高珊,刘克坚,邱强.冠心病诊断技术研究进展[J].中华实用诊断与治疗杂志,2010,24(4):318-320. 被引量:19
  • 6Horowitz J D, Heresztyn T. An overview of plasmaconcentrations of asymmetric dimethylarginine ( ADMA) inhealth and disease and in clinical studies:methodologicalconsiderations![J]. J Chromatogr B Analyt Technol Biomed LifeSci,2007,851(1/2) ..42-50.
  • 7Teerlink T,Nijveldt R J,de Jong S,et al. Determination ofarginine, asymmetric dimethylarginine, and symmetricdimethylarginine in human plasma and other biological samplesby high-performance liquid chromatography [J]. Anal Biochem,2002,303C2):131-137.
  • 8Jones C E, Darcy C J, Woodberry T, et al. HPLC analysis ofasymmetric dimethylarginine, symmetric dimethylarginine,homoarginine and arginine in small plasma volumes using aGemini-NX column at high pH [ J ]. J Chromatogr B AnalytTechnol Biomed Life Sci, 2010,878(1):8-12.
  • 9张润香,李菊香,熊玉卿,夏春华.HPLC测定人血浆中不对称性二甲精氨酸浓度[J].江西医学院学报,2003,43(4):19-21. 被引量:5

二级参考文献18

共引文献22

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部